News Releases

Cannabix Technologies to Test Contactless Alcohol Breathalyzer (CAB) in Montana

February 13, 2023

Vancouver, British Columbia, February 13, 2023 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of breath testing devices for law enforcement and the workplace reports that Friedel, LLC (“Friedel Clinic”) based in Montana will commence piloting Cannabix’s  Contactless Alcohol Breathalyzer (“CAB”). In the fall of 2022, the Company developed its CAB technology for workplaces and vehicles that consist of wall-mounted and in-vehicle versions.  The Friedel Clinic has a robust drug testing operation and is one of the top drug testing providers to employers within the state of Montana. The high-volume clinic has a diverse range of patients and focuses on private sector testing for alcohol and illicit drugs.  The Friedel Clinic has extensive experience piloting with new alcohol and drug testing technologies. Video of the CAB device can be viewed here.

Montana Senator Chris Friedel stated, “The Friedel Clinic has been a pioneer in alcohol, drug and brain health testing in the state of Montana. We have tremendous amount of experience with a range of new testing and monitoring equipment. In addition, we are excited to see how the Cannabix Contactless Alcohol Breathalyzer devices can enhance safety in both workplace and in-vehicle settings – in particular the potential to disrupt legacy alcohol interlock methods which have seen little innovation over the last 40 years.”

The wall mounted CAB would be targeted for employers needing to deploy a pre-access test for alcohol consumption before and during work hours in a fast and cost-effective way. The CAB technology allows for a user to direct a single breath sample towards a small orifice integrated into a wall mounted unit (for indoor use) and behind the steering wheel for in-cabin vehicle use – in a completely contactless manner. The CAB is fundamentally different than existing alcohol breathalyzers and interlock systems that require users to use a mouthpiece or straw and directly blow into a handheld device that is connected to the vehicle usually with a cable. The Cannabix CAB could be integrated into various locations in the vehicle cabin. The CAB provides a warning, pass or fail result along with a Blood Alcohol Content (BAC) level on the screen for the driver to see. This kind of technology holds potential to be integrated with interlock systems and be used in various settings including automotive, heavy-duty equipment, heavy transport vehicles, watercraft and motorbikes. Furthermore, the device could be used in bars, restaurants and hotels for both patrons and employees.

 Vehicle Alcohol Breath Screening

The Company has developed its CAB technology in response to interest in new vehicle alcohol detection technologies.  In September 2022, the National Transportation Safety Board (NTSB) issued a recommendation that all new vehicles be equipped with technology that would prevent a person impaired by alcohol from driving (1).  In November 2021, the U.S. House of Representatives, passed the Infrastructure Investment and Jobs Act (IIJA) which called for new cars to come equipped with technology that will detect alcohol in breath. The legislation directed the National Highway Traffic Safety Administration to set new safety standards within three years for impaired driving safety equipment on all new vehicles (2) (3).

Manufacturers such as Volvo have experimented with offering alcohol-detection systems as optional equipment.




Readers are advised that, although the Company has achieved proof of concept prototype for the CAB, the testing method and device is still in the preapproval stage and accordingly the Company is not currently making any express or implied claims that the technology will proceed to commercial use.

The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.